VP of Venture Capital, Pfizer Inc.
Member, NASA Technology Roadmap Review Steering Committee
Research Fellow, MIT Sloan School and Entrepreneurship Center
Dean, University of San Diego School of Law
Dean, College of Engineering, University of Michigan
CEO, Aires Pharmaceuticals and Palkion
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
Head of global research and development at Life Technologies.
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Q&A With Bob Tepper on What’s Next for Third Rock Ventures | Luke Timmerman | 03/26/13 | Boston | |
| East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More | Bernadette Tansey | 02/15/13 | National | |
| Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy | Luke Timmerman | 02/14/13 | Boston | |
| Jounce Therapeutics Garners $47,000,000 Series A Financing Round | VentureDeal | 02/14/13 | Boston | |
| Page 1 of 1 | ||||